rotenone has been researched along with Cancer of Mouth in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PS; Hong, CY; Hsiao, M; Hsiao, YW; Lai, TC; Lee, CH; Lee, JJ; Lin, SK; Liu, WT; Liu, YP; Lu, PJ; Ping Kuo, MY | 1 |
| Bisen, PS; Bundela, S; Sharma, A | 1 |
| Hsiao, M; Huang, MS; Kuo, MY; Lai, TC; Lee, J; Pang, VF; Wang, JL; Yang, IC | 1 |
3 other study(ies) available for rotenone and Cancer of Mouth
| Article | Year |
|---|---|
Suppressive function of low-dose deguelin on the invasion of oral cancer cells by downregulating tumor necrosis factor alpha-induced nuclear factor-kappa B signaling.
Topics: Animals; Cell Line, Tumor; Female; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred NOD; Mice, SCID; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Rotenone; Signal Transduction; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2016 |
Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.
Topics: Administration, Oral; Algorithms; Antineoplastic Agents; Berberine; Bortezomib; Colchicine; Databases, Pharmaceutical; Databases, Protein; Diterpenes; Humans; Hydroxamic Acids; Limonins; Lovastatin; Models, Statistical; Mouth Neoplasms; Predictive Value of Tests; Resveratrol; Rotenone; Stilbenes; Support Vector Machine; Vorinostat | 2015 |
Essential roles of caspases and their upstream regulators in rotenone-induced apoptosis.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Caspase 9; Cell Division; Cell Line, Tumor; Cell Proliferation; Cytochromes c; G2 Phase; Humans; Mouth Neoplasms; Rotenone; Tumor Suppressor Protein p53 | 2008 |